GlassScriptPhysician profile
James Dewitt Cross
NPI 1326326588
$72,827.96
in general payments reported to CMS, 2019-2025
14 companies · $4,069 in 2025
The $4,069 reported for 2025 was more than what 98% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35K · 2020: $16K · 2021: $2,075 · 2022: $1,892 · 2024: $14K · 2025: $4,069.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,993.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $13,177.70 | 2019-2022 | |
| Allergan, INC. | $13,174.50 | 2019-2020 | |
| Medtronic, INC. | $12,993.75 | 2024-2025 | Gi Genius |
| Abbott Laboratories | $11,287.50 | 2019-2021 | |
| Aerin Medical INC. | $5,000.00 | 2024 | |
| Intersect Ent, INC. | $3,500.00 | 2019-2020 | |
| Pacira Therapeutics, INC. | $2,875.00 | 2020-2021 | |
| Hologic INC | $2,763.55 | 2019-2022 | |
| Hologic Sales and Service, LLC | $2,675.28 | 2020 | |
| Gen-Probe, INC. | $2,065.49 | 2019 | |
| Baxter Healthcare | $2,000.00 | 2019 | |
| Depuy Synthes Products, INC. | $1,147.50 | 2019 | |
| Ethicon INC. | $127.50 | 2019 | |
| Vertos Medical, INC. | $40.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Cross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.